Diaconu, A.-D.; Pomîrleanu, C.; Russu, M.; Strugariu, G.; Ancuța, E.; Ciortescu, I.; Bologa, C.; Morărașu, B.C.; Constantin, M.; Ceasovschih, A.;
et al. Drug Survival, Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis up to 4 Years: A Real-Life Single Center Experience. J. Pers. Med. 2024, 14, 417.
https://doi.org/10.3390/jpm14040417
AMA Style
Diaconu A-D, Pomîrleanu C, Russu M, Strugariu G, Ancuța E, Ciortescu I, Bologa C, Morărașu BC, Constantin M, Ceasovschih A,
et al. Drug Survival, Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis up to 4 Years: A Real-Life Single Center Experience. Journal of Personalized Medicine. 2024; 14(4):417.
https://doi.org/10.3390/jpm14040417
Chicago/Turabian Style
Diaconu, Alexandra-Diana, Cristina Pomîrleanu, Mara Russu, Georgiana Strugariu, Eugen Ancuța, Irina Ciortescu, Cristina Bologa, Bianca Codrina Morărașu, Mihai Constantin, Alexandr Ceasovschih,
and et al. 2024. "Drug Survival, Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis up to 4 Years: A Real-Life Single Center Experience" Journal of Personalized Medicine 14, no. 4: 417.
https://doi.org/10.3390/jpm14040417
APA Style
Diaconu, A.-D., Pomîrleanu, C., Russu, M., Strugariu, G., Ancuța, E., Ciortescu, I., Bologa, C., Morărașu, B. C., Constantin, M., Ceasovschih, A., Șorodoc, V., Șorodoc, L., & Ancuța, C.
(2024). Drug Survival, Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis up to 4 Years: A Real-Life Single Center Experience. Journal of Personalized Medicine, 14(4), 417.
https://doi.org/10.3390/jpm14040417